Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Shl Telemedicine (0QMX) AI Stock Analysis

GB:0QMX

Shl Telemedicine

(LSE:0QMX)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Return to Revenue GrowthThe return to 8.2% revenue growth in 2025 indicates renewed demand or improved commercial execution after a period of stagnation. If maintained, expanding revenue can improve operating leverage, support investment in telehealth capabilities, and provide a stronger base for eventual profitability.
Negative Factors
Persistent Net LossesPersistent and deep net losses weaken earnings quality and reduce the company’s ability to reinvest from internally generated profits. Continued losses can also erode equity over time, constrain strategic flexibility, and make a durable improvement in shareholder returns dependent on a successful profitability turnaround.

Shl Telemedicine (0QMX) vs. iShares MSCI United Kingdom ETF (EWC)

-80%-60%-40%-20%0%20%40%GB:0QMX-52.88%EWC+23.59%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CHF 37.80M
Dividend Yield
―
Average Volume (3M)
13
Price to Earnings (P/E)
-2.2
Beta (1Y)
0.36
Revenue Growth
-0.04%
EPS Growth
46.39%
Country
UK
Employees
526
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Shl Telemedicine Business Overview & Revenue Model

Company Description

Established in 1987 and headquartered in Tel Aviv, Israel, SHL Telemedicine Ltd. is a global provider specializing in the development and distribution of individual remote healthcare solutions across Israel, Europe, and other international markets. T...

Shl Telemedicine Peers Comparison

Overall Rating

Financial Indicators

GB:0QMX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-60%-40%-20%0%GB:0QMXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:0QMX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0QMXShl Telemedicine 1.07-1.20-52.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.